Answers are grounded in this paper and cite their sources.
• HAp/Col nanocomposite exhibited vascular invasion within 3 days in a rat calvarial model. • Osteoclast recruitment and osteoblast activation contributed to bone remodeling within the scaffold. • CTHRC1 expression increased over time, suggesting a potential coupling role in osteogenesis. • The porous, space-forming structure of HAp/Col permitted tissue infiltration and peri-material bone formation, with no apparent detrimental tissue reactions observed. • HAp/Col demonstrated biocompatibility and safety as a candidate biomaterial for medical and dental applications. The development of biomaterials that actively promote bone regeneration remains a major challenge in regenerative medicine and dentistry. This study investigated the time-dependent osteogenic potential of an organic-inorganic composite bone filler (hydroxyapatite/collagen bone-like nanocomposite, HAp/Col) using a rat calvarial model, assessed by immunohistochemistry and bone histomorphometry. By day 3, vascular endothelial growth factor receptor 2 (VEGFR2)-positive cells were detected on the HAp/Col surface, indicating early vascular invasion. By day 5, vascular infiltration had extended into the scaffold, where double staining with tartrate resistant acid phosphatase (TRAP)/ alkaline phosphatase (ALP) revealed osteoclast-mediated material absorption and osteoblast-mediated bone matrix deposition around vascular cavities. By day 7, bone remodeling within HAp/Col was markedly active, with clusters of osteoblasts producing new bone matrix. Outside the scaffold, osteoblasts adhered to its surface and elongated, enhancing bone formation through the space-forming effect of HAp/Col swelling. Furthermore, collagen triple helix repeat-containing protein 1 (CTHRC1) expression increased progressively from days 3 to 7, as confirmed by immunostaining and qRT-PCR, suggesting its role as a coupling factor between osteoclast activity and osteoblast differentiation. These findings suggest that HAp/Col is associated with cellular activities related to bone remodeling, including vascular invasion and osteoclast/osteoblast recruitment. HAp/Col demonstrates biocompatibility and in vivo tissue compatibility as a candidate biomaterial for medical and dental applications.
No takes yet. Share an insight, caveat, or question.
Arai et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: